Author

Y. Wakabayashi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:mouse· 1

Frequent Co-Authors

E. Furukawa· 1 shared E. Kita· 1 shared H. Kogashi· 1 shared J. Lin· 1 shared J. Nakayama· 1 shared K. Kugou· 1 shared K. Nakamichi· 1 shared K. Nakatani· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

E. Furukawa

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Global changes in open reading frame dominance of RNAs during cancer initiation and progression

Y. Suenaga, H. Kogashi, K. Nakatani, J. Lin, Y. Hasegawa, K. Kugou, Y. Kawashima, E. Furukawa, K. Okumura, E. Kita, Y. Wakabayashi, M. Kato, M. Kawazu, Y. Hippo

The paper measures ORF dominance in cancer and finds it increases with carcinogenesis, correlates with translation, and blurs coding/noncoding boundaries before metastasis.

bioRxiv · Jun 2, 2023 · PreprintCancer Biology

Targeting c-Jun is a potential therapy of luminal breast cancer bone metastasis

Y. Han, M. Futakuchi, K. Nakamichi, Y. Wakabayashi, M. Sakamoto, J. Nakayama, K. Semba

This study identifies c-Jun as a novel marker for luminal breast cancer bone metastasis and shows its inhibition reduces metastatic potential.

bioRxiv · Jul 17, 2022Cancer Biology